Merial and Boehringer Ingelheim Vetmedica Inc. announce a co-marketing agreement for the MERIAL SUREHEALTH calf-preconditioning program, designed to create a more robust offering of eligible products. The SUREHEALTH program features best management practices that add value to feeder calves throughout the production chain.

"Our goal is to offer the best combination of health protocols and products inside a comprehensive calf-preconditioning program," says Jim Van Proosdy, Merial senior director of large animal sales. "By combining the product lines of two reputable animal health companies with a set of proven preconditioning protocols developed by the beef industry, we believe that we're offering the best calf-preconditioning program in this country."

As part of the agreement, the number of qualified products will grow to include brands from both Boehringer Ingelheim Vetmedica and Merial. These include, Bar-Vac 7/somnus, Bar-Vac 8, Pulmo-guard Pasteurella and Pulmo-guard MpB (Mycoplasma bovis) vaccines; Caliber , Elite , Express , RELIANT and RESPISHIELD brand vaccines; IVOMEC (ivermectin) and EPRINEX (eprinomectin) brand endectocides; and CORID (amprolium), an optional prevention/treatment for coccidiosis.

In total, Boehringer Ingelheim Vetmedica will market 10 vaccines and Merial will market another 16 cattle products inside the SUREHEALTH program. The 26 products can be mixed and matched as long as they meet the minimum requirements for SUREHEALTH certification. Each company will sell its own brands used inside the program, but both companies' sales forces will implement the program.

Source: Company Releases